When proposals for a vascular screening programme have been developed further the Department intends to consult with various stakeholders including the National Screening Committee, the National Institute for Health and Clinical Excellence and a number of interested groups such as leading voluntary groups.
These assessments form part of the modelling work on the clinical and cost-effectiveness of a systematic, population-wide vascular risk assessment and management programme that is currently being carried out by the Department’s analysts.
There is a departmental project currently under way to assess costs and benefits of an integrated, systematic population-wide vascular risk screening programme.
The exact nature of a vascular risk assessment and management programme is still the subject of developmental work. It would be premature at this stage to set out specific spending figures on advertising and education campaigns.
Take-up rates for a new service are, by their nature, unpredictable and will depend on the details of what is offered to whom, which will be worked out in part in discussions with stakeholders. However, a range of assumptions about likely take-up levels of a vascular risk assessment programme will be modelled into the analytical work being undertaken by the Department. Assumptions about likely take-up will also form part of the discussions we will have with stakeholders about the development of the practical aspects of the programme.